- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 1/22 - Affinity chromatography or related techniques based upon selective absorption processes
Patent holdings for IPC class C07K 1/22
Total number of patents in this class: 2032
10-year publication summary
145
|
159
|
164
|
147
|
173
|
160
|
189
|
179
|
149
|
42
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Cytiva BioProcess R&D AB | 287 |
89 |
Regeneron Pharmaceuticals, Inc. | 3650 |
69 |
Kaneka Corporation | 4445 |
59 |
EMD Millipore Corporation | 657 |
34 |
Genentech, Inc. | 3742 |
31 |
Amgen Inc. | 3779 |
29 |
JSR Corporation | 2476 |
29 |
GE Healthcare Bio-Sciences AB | 570 |
25 |
Merck Patent GmbH | 5909 |
24 |
Bio-Rad Laboratories, Inc. | 1592 |
21 |
Bristol-myers Squibb Company | 5080 |
20 |
Hoffmann-La Roche Inc. | 3060 |
20 |
Tosoh Corporation | 1127 |
20 |
Navigo Proteins GmbH | 101 |
19 |
F. Hoffmann-La Roche AG | 7958 |
18 |
Daicel Corporation | 2128 |
17 |
Abbvie Inc. | 1808 |
16 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
16 |
Merck Millipore Ltd. | 46 |
16 |
Genzyme Corporation | 1205 |
15 |
Other owners | 1445 |